Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats

Brain Research

Volumn 1372, Issue , 2011, Pages 115-126

  Kalonia, Harikesh ^a   Kumar, Puneet ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Calcium channel blockers; Inflammatory cytokines; Motor dysfunction; Oxidative stress; Quinolinic acid

Indexed keywords

CASPASE 3; CYTOKINE; DILTIAZEM; INTERLEUKIN 6; QUINOLINIC ACID; TUMOR NECROSIS FACTOR ALPHA; VERAPAMIL;

APOPTOSIS; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CORPUS STRIATUM; DRUG EFFECT; HUNTINGTON DISEASE LIKE SYNDROME; LOCOMOTION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROPROTECTION; OXIDATION; PRIORITY JOURNAL; ROTAROD TEST; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; CATALASE; CYTOKINES; DILTIAZEM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUNTINGTON DISEASE; LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NITRITES; PSYCHOMOTOR PERFORMANCE; QUINOLINIC ACID; RATS; RATS, WISTAR; VERAPAMIL;

ANIMALIA; RATTUS;

EID: 79151479222     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.11.060     Document Type: Article

References (90)

1. D.M. Araujo, S.R. Cherry, K.J. Tatsukawa, T. Toyokuni, and H.I. Kornblum Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease Exp. Neurol. 166 2000 287 297
2. M. Arundine, and M. Tymianski Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity Cell Calcium 34 2003 325 337
3. M.F. Beal Energetics in the pathogenesis of neurodegenerative diseases Trends Neurosci. 23 2000 298 304
4. M. Bishnoi, K. Chopra, and S.K. Kulkarni Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study Neurochem. Res. 33 2008 1869 1880
5. M. Björkqvist, E.J. Wild, J. Thiele, A. Silvestroni, R. Andre, N. Lahiri, E. Raibon, R.V. Lee, C.L. Benn, D. Soulet, A. Magnusson, B. Woodman, C. Landles, M.A. Pouladi, M.R. Hayden, A. Khalili-Shirazi, M.W. Lowdell, P. Brundin, G.P. Bates, B.R. Leavitt, T. Möller, and S.J. Tabrizi A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease J. Exp. Med. 205 2008 1869 1877
6. D. Blum, A. Chtarto, L. Tenenbaum, J. Brotchi, and M. Levivier Clinical potential of minocycline for neurodegenerative disorders Neurobiol. Dis. 17 2004 359 366
7. Y.M. Bordelon, M.F. Chesselet, M. Erecińska, and I.A. Silver Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo Neuroscience 83 1998 459 469
8. N. Braidy, R. Grant, S. Adams, and G.J. Guillemin Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons FEBS J. 277 2010 368 382
9. E. Brouillet, F. Conde, M.F. Beal, and P. Hantraye Replicating Huntington's disease phenotype in experimental animals Prog. Neurobiol. 59 1999 427 468
10. S.L. Budd, and D.G. Nicholls Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells J. Neurochem. 67 1996 2282 2291
11. C. Burkhardt, J.P. Kelly, Y.H. Lim, C.M. Filley, and W.D. Parker Neuroleptic medications inhibit complex II of the electron transport chain Ann. Neurol. 33 1993 512 517
12. N.G. Carlson, W.A. Wieggel, J. Chen, A. Bacchi, S.W. Rogers, and L.C. Gahring Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways J. Immunol. 163 1999 3963 3968
13. J.H. Cha Transcriptional dysregulation in Huntington's disease Trends Neurosci. 23 2000 387 392
14. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, S. Zhu, J. Bian, L. Guo, L.A. Farrell, S.M. Hersch, W. Hobbs, J.P. Vonsattel, J.H. Cha, and R.M. Friedlander Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat. Med. 6 2000 797 801
15. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 1988 623 634
16. D.W. Choi Calcium: still center-stage in hypoxic-ischemic neuronal death Trends Neurosci. 18 1995 58 60
17. P.J. Cullen, and P.J. Lockyer Integration of calcium and ras signaling Nat. Rev. Mol. Cell Biol. 3 2002 339 348
18. Y. Deng, Z. Xu, B. Xu, Y. Tian, X. Deng, X. Xin, and J. Gao Excitotoxicity in rat's brain induced by exposure of manganese and neuroprotective effects of pinacidil and nimodipine Biol. Trace Elem. Res. 131 2009 143 153
19. M. Dragunow, R.L. Faull, P. Lawlor, E.J. Beilharz, K. Singleton, E.B. Walker, and E. Mee In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes NeuroReport 6 1995 1053 1057
20. D. Elinos-Calderón, Y. Robledo-Arratia, V. Pérez-De La Cruz, P.D. Maldonado, S. Galván-Arzate, J. Pedraza-Chaverrí, and A. Santamaría Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine J. Neural Transm. 117 2010 35 44
21. M.M. Fan, and L.A. Raymond N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease Prog. Neurobiol. 81 2007 272 293
22. A.M. Fernandes, A.M. Landeira-Fernandez, P. Souza-Santos, P.C. Carvalho-Alves, and R.F. Castilho Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2+-ATPase function Neurochem. Res. 33 2008 1749 1758
23. A.G. Gornall, C.J. Bardawill, and M.M. David Determination of serum proteins by means of the biuret reaction J. Biol. Chem. 177 1949 751 766
24. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannebaum Analysis of nitrate, nitrite, and [15N) nitrate in biological fluids Ann. Biochem. 126 1982 131 138
25. S. Gunawardena, L.S. Her, R.G. Brusch, R.A. Laymon, I.R. Niesman, B. Gordesky-Gold, L. Sintasath, N.M. Bonini, and L.S. Goldstein Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila Neuron 40 2003 25 40
26. K. Hernández-Fonseca, N. Cárdenas-Rodríguez, J. Pedraza-Chaverri, and L. Massieu Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons J. Neurosci. Res. 86 2008 1768 1780
27. T. Himeda, S. Kanbara, C. Oki, H. Kato, and T. Araki Effects of chronic administration with nilvadipine against immunohistochemical changes related to aging in the mouse hippocampus Metab. Brain Dis. 20 2005 141 153
28. S. Hunot, and E.C. Hirsch Neuroinflammatory processes in Parkinson's disease Ann. Neurol. 53 2003 S49 S58
29. J. Hydman, S. Remahl, G. Bjorck, M. Svensson, and P. Mattsson Nimodipine improves reinnervation and neuromuscular function after injury to the recurrent laryngeal nerve in the rat Ann. Otol. Rhinol. Laryngol. 116 2007 623 630
30. V. Jackson-Lewis, and S. Przedborski Neuroleptic medications inhibit complex I of the electron transport chain Ann. Neurol. 35 1994 244 245
31. C. Jacquard, Y. Trioulier, F. Cosker, C. Escartin, N. Bizat, P. Hantraye, J.M. Cancela, G. Bonvento, and E. Brouillet Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation FASEB J. 20 2006 1021 1023
32. H. Kalonia, P. Kumar, A. Kumar, and B. Nehru Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats Neurotoxicology 31 2010 195 203
33. H. Kalonia, P. Kumar, B. Nehru, and A. Kumar Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats Indian J. Exp. Biol. 47 2009 880 892
34. Y. Kono Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase Arch. Biochem. Biophys. 186 1978 189 195
35. F. Kouoh, B. Gressier, T. Dine, M. Luyckx, C. Brunet, L. Ballester, and J.C. Cazin Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential anti-atherosclerotic property of calcium antagonists? Cardiovasc. Drugs Ther. 16 2002 515 520
36. Z. Kristofiková, F. Stástný, V. Bubeniková, R. Druga, J. Klaschka, and F. Spaniel Age- and sex-dependent laterality of rat hippocampal cholinergic system in relation to animal models of neurodevelopmental and neurodegenerative disorders Neurochem. Res. 29 2004 671 680
37. F. Leblhuber, J. Walli, K. Jellinger, G.P. Tilz, B. Widner, F. Laccone, and D. Fuchs Activated immune system in patients with Huntington's disease Clin. Chem. Lab. Med. 36 1998 747 750
38. M. Leist, and P. Nicotera Calcium and neuronal death Rev. Physiol. Pharmacol. Biochem. 132 1997 79 125
39. Y. Li, X. Hu, Y. Liu, and Y. Bao An L.Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation Neuropharmacology 56 2009 580 589
40. C.S. Lobsiger, and D.W. Cleveland Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease Nat. Neurosci. 10 2007 1355 1360
41. Y.M. Lu, J.T. Zhang, F.Q. Zhao, and Y.F. Qin Effects of Ca2+ antagonists on glutamate release and Ca2+ influx in the hippocampus with in vivo intracerebral microdialysis Br. J. Pharmacol. 104 1991 222 226
42. Luck H. Catalase Bergmeyer H.U. Methods of Enzymatic Analysis 1971 Academic Press New York 885 893
43. V. Mary, F. Wahl, and J.M. Stutzmann Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission Neurosci. Lett. 201 1995 92 96
44. E. Matyja, and E. Kida Protective effect of nimodipine against quinolinic acid-induced damage of rat hippocampus in vitro Neuropatol. Pol. 29 1991 69 77
45. L. Minghetti, A. Greco, R.L. Potenza, A. Pezzola, D. Blum, K. Bantubungi, and P. Popoli Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration J. Neuropathol. Exp. Neurol. 66 2007 363 371
46. P. Mukherjee, and G.M. Pasinetti The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease J. Neuroimmunol. 105 2000 124 130
47. M. Nakai, Z. Qin, Y. Wang, and T.N. Chase NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117 Brain Res. 859 2000 207 216
48. J.W. Olney Excitotoxic amino acids and neuropsychiatric disorders Annu. Rev. Pharmacol. Toxicol. 30 1990 47 71
49. V.O. Ona, M. Li, J.P. Vonsattel, L.J. Andrews, S.Q. Khan, W.M. Chung, A.S. Frey, A.S. Menon, X.J. Li, P.E. Stieg, J. Yuan, J.B. Penney, A.B. Young, J.H. Cha, and R.M. Friedlander Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease Nature 399 1999 263 267
50. M. Ouardouz, G.W. Zamponi, W. Barr, L. Kiedrowski, and P.K. Stys Protection of ischemic rat spinal cord white matter: dual action of KB-R7943 on Na+/Ca2+ exchange and L-typeCa2+ channels Neuropharmacology 48 2005 566 575
51. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736
52. F. Paquet-Durand, A. Gierse, and G. Bicker Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia Brain Res. 1124 2006 45 54
53. N. Pavese, A. Gerhard, Y.F. Tai, A.K. Ho, F. Turkheimer, R.A. Barker, D.J. Brooks, and P. Piccini Microglial activation correlates with severity in Huntington disease: a clinical and PET study Neurology 66 2006 1638 1643
54. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates 6th edition 2007 Academic Press San Diego 256
55. L.A. Pemberton, S.J. Kerr, G. Smythe, and B.J. Brew Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha J. Interferon Cytokine Res. 17 1997 589 595
56. T.I. Peng, and J.T. Greenamyre Privileged access to mitochondria of calcium influx through N-methyl-d-aspartate receptors Mol. Pharmacol. 53 1998 974 980
57. V. Pérez-De La Cruz, D. Elinos-Calderón, Y. Robledo-Arratia, O.N. Medina-Campos, J. Pedraza-Chaverrí, S.F. Ali, and A. Santamaría Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease Behav. Brain Res. 199 2009 210 217
58. V. Pérez-De La Cruz, M. Konigsberg, J. Pedraza-Chaverri, N. Herrera-Mundo, M. Díaz-Muñoz, J. Morán, T. Fortoul-van der Goes, A. Rondán-Zárate, P.D. Maldonado, S.F. Ali, and A. Santamaría Cytoplasmic calcium mediates oxidative damage in an excitotoxic/energetic deficit synergic model in rats Eur. J. Neurosci. 27 2008 1075 1085
59. R.F. Pfeiffer Parkinson disease: calcium channel blockers and Parkinson disease Nat. Rev. Neurol. 6 2010 188 189
60. M. Pizzi, M. Ribola, A. Valerio, M. Memo, and P. Spano Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity Eur. J. Pharmacol. 209 1991 169 173
61. K. Saito, S.P. Markey, and M.P. Heyes Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse Neuroscience 51 1992 25 39
62. E. Salińska, W. Danysz, and J.W. Łazarewicz The role of excitotoxicity in neurodegeneration Folia Neuropathol. 43 2005 322 339
63. I. Sánchez, C.J. Xu, P. Juo, A. Kakizaka, J. Blenis, and J. Yuan Caspase-8 is required for cell death induced by expanded polyglutamine repeats Neuron 22 1999 623 633
64. A. Santamaría, and C. Ríos MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum Neurosci. Lett. 159 1993 51 54
65. E. Sapp, K.B. Kegel, N. Aronin, T. Hashikawa, Y. Uchiyama, K. Tohyama, P.G. Bhide, J.P. Vonsattel, and M. DiFiglia Early and progressive accumulation of reactive microglia in the Huntington disease brain J. Neuropathol. Exp. Neurol. 60 2001 161 172
66. R. Sattler, and M. Tymianski Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death Mol. Neurobiol. 24 2001 107 129
67. P.J. Schwartz, A. Reaume, R. Scott, and J.T. Coyle Effects of over- and under-expression of Cu, Zn-superoxide dismutase on toxicity of glutamate analogs in transgenic mouse striatum Brain Res. 789 1998 32 39
68. D.A. Simmons, M. Casale, B. Alcon, N. Pham, N. Narayan, and G. Lynch Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease Glia 55 2007 1074 1084
69. N.A. Simonian, and J.T. Coyle Oxidative stress in neurodegenerative diseases Annu. Rev. Pharmacol. Toxicol. 36 1996 83 106
70. S.K. Singhrao, J.W. Neal, B.P. Morgan, and P. Gasque Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease Exp. Neurol. 159 2 1999 362 376
71. C. Song, Y. Zhang, C.G. Parsons, and Y.F. Liu Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors J. Biol. Chem. 278 2003 33364 33369
72. T.W. Stone, and W.M. Behan Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist J. Neurosci. Res. 85 2007 1077 1085
73. W.J. Streit Microglia and Alzheimer's disease pathogenesis J. Neurosci. Res. 77 2004 1 8
74. G. Szebenyi, G.A. Morfini, A. Babcock, M. Gould, K. Selkoe, D.L. Stenoien, M. Young, P.W. Faber, M.E. MacDonald, M.J. McPhaul, and S.T. Brady Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport Neuron 40 2003 41 52
75. K. Szydlowska, and M. Tymianski Calcium, ischemia and excitotoxicity Cell Calcium 47 2010 122 129
76. T.S. Tang, H. Tu, E.Y. Chan, A. Maximov, Z. Wang, C.L. Wellington, M.R. Hayden, and I. Bezprozvanny Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1, 4, 5) triphosphate receptor type 1 Neuron 39 2003 227 239
77. S.A. Thayer, Y.M. Usachev, and W.J. Pottorf Modulating Ca2+ clearance from neurons Front. Biosci. 7 2002 d1255 d1279
78. L.B. Thomas, D.J. Gates, E.K. Richfield, T.F. O'Brien, J.B. Schweitzer, and D.A. Steindler DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions Exp. Neurol. 133 1995 265 272
79. P.J. Torreano, and C.S. Cohan Calcium and voltage dependent inactivation of sodium and calcium currents limits calcium influx in Helisoma neurons J. Neurobiol. 54 2003 439 456
80. G. Tsai, D.C. Goff, R.W. Chang, J. Flood, L. Baer, and J.T. Coyle Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia Am. J. Psychiatry 155 1998 1207 1213
81. S. Umemoto, M. Tanaka, S. Kawahara, M. Kubo, K. Umeji, R. Hashimoto, and M. Matsuzaki Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats Hypertens. Res. 27 2004 877 885
82. A. Volterra, D. Trotti, C. Tromba, S. Floridi, and G. Racagni Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes J. Neurosci. 14 1994 2924 2932
83. X. Wang, X. Gao, X. Zhang, Y. Tu, M.L. Jin, G.P. Zhao, L. Yu, N.H. Jing, and B.M. Li The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning Biochem. Biophy. Res. Comm. 340 2006 1023 1027
84. X. Wang, S. Zhu, M. Drozda, W. Zhang, I.G. Stavrovskaya, E. Cattaneo, R.J. Ferrante, B.S. Kristal, and R.M. Friedlander Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease Proc. Natl Acad. Sci. USA 100 2003 10483 10487
85. J.H. Weiss, D.M. Hartley, J. Koh, and D.W. Choi The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity Science 247 1990 1474 1477
86. C.L. Wellington, L.M. Ellerby, B.R. Leavitt, S. Roy, D.W. Nicholson, and M.R. Hayden Huntingtin proteolysis in Huntington disease Clin. Neurosci. Res. 3 2003 129 139
87. E.D. Wills Mechanisms of lipid peroxide formation in animal tissues Biochem. J. 99 1966 667 676
88. M.M. Zeron, O. Hansson, N. Chen, C.L. Wellington, B.R. Leavitt, P. Brundin, M.R. Hayden, and L.A. Raymond Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 2002 849 860
89. Y. Zhang, V.O. Ona, M. Li, M. Drozda, M. Dubois-Dauphin, S. Przedborski, R.J. Ferrante, and R.M. Friedlander Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease J. Neurochem. 87 2003 1184 1192
90. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, L. Conti, T. Cataudella, B.R. Leavitt, M.R. Hayden, T. Timmusk, D. Rigamonti, and E. Cattaneo Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat. Genet. 35 2003 76 83